Easywell Biomedicals Balance Sheet Health
Financial Health criteria checks 6/6
Easywell Biomedicals has a total shareholder equity of NT$745.2M and total debt of NT$44.5M, which brings its debt-to-equity ratio to 6%. Its total assets and total liabilities are NT$1.4B and NT$653.8M respectively.
Key information
6.0%
Debt to equity ratio
NT$44.45m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$433.19m |
| Equity | NT$745.19m |
| Total liabilities | NT$653.80m |
| Total assets | NT$1.40b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 1799's short term assets (NT$676.7M) exceed its short term liabilities (NT$168.3M).
Long Term Liabilities: 1799's short term assets (NT$676.7M) exceed its long term liabilities (NT$485.5M).
Debt to Equity History and Analysis
Debt Level: 1799 has more cash than its total debt.
Reducing Debt: 1799's debt to equity ratio has reduced from 13.5% to 6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1799 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1799 has sufficient cash runway for 1.4 years if free cash flow continues to grow at historical rates of 15.1% each year.